Conclusion
Our data suggests that low FT3 levels at admission are independently associated with poor outcome in acute ischemic stroke after 3 months. Further investigations are needed to explore the mechanisms underlying the association and their potential exploitation in terms of therapeutic strategies to reduce disability after acute ischemic stroke.